AFP and hepatocellular carcinoma: This may be because, in addition to the inclusion of assessment factors (tumor diameter, tumor number, and combined vascular invasion) that are widely used in these staging systems, we included other clinicopathological patient features, such as combined MVI, elevated AFP, and elevated ALP, which have been shown to significantly affect the prognosis of patients with HCC (12–14).